MDH Tuberculosis (TB) Prevention and Control Program- Minnesota Dept. of Health

Tuberculosis (TB) Prevention and Control Program

On this page:
Program Objectives
Contact information


Eliminate tuberculosis in Minnesota.


The mission of the Minnesota Department of Health TB Prevention and Control Program is to provide leadership and expertise to reduce the incidence of tuberculosis in Minnesota.


The Minnesota Department of Health TB Prevention and Control Program, in collaboration with local public health departments and health care professionals statewide, collects and analyzes surveillance data to monitor epidemiologic trends and provides consultation to clinicians and local public health departments to assure appropriate clinical management and adequate therapy for TB patients and persons exposed to TB disease. In addition, MDH collaborates with community-based organizations and voluntary agencies to reach communities affected by TB; facilitates screening of persons at high risk for TB; provides TB-related education for health care providers, public health professionals, and the general public; and coordinates and administers a statewide program to provide TB medications.

The specific services provided by the TB Program are summarized below:

1. Disease Surveillance/Epidemiology

  • Compile standardized case reports for all TB cases reported in Minnesota.
  • Notify local health departments regarding all newly-reported TB cases in their jurisdiction.
  • Analyze and summarize data regarding the epidemiology of TB in Minnesota; distribute these data to health care providers and public health agencies statewide.
  • Report surveillance data and programmatic outcomes to the Centers for Disease Control and Prevention (CDC).
  • Conduct or participate in epidemiologic studies regarding TB in Minnesota and nationally; summarize and distribute results to the appropriate audiences.

2. Case Management/Contact Investigation

  • Through regular contact with physicians and public health nurses, monitor the status of individual TB cases to ensure that appropriate medications are supplied, that patients receive regular medical follow-up and adhere to drug regimens, that clinical response to therapy is documented - all as indicated in national guidelines.
  • Work with local health departments to ensure that complete and timely epidemiologic ("contact") investigations are conducted surrounding infectious TB cases in Minnesota; analyze and summarize the findings of TB contact investigations; provide feedback to local agencies.
  • Receive and send interstate referrals for TB patients who move between jurisdictions during their course of TB treatment.
  • Administer grant funding to local public health departments and public TB clinics, as resources are available, to facilitate the provision of culturally-appropriate TB outreach services.

3. Consultation/Education

  • Consult with health care providers and local health departments about standard recommendations regarding diagnostic procedures, treatment regimens, clinical follow-up, and TB contact investigations.
  • Disseminate national guidelines and other provider and patient education materials.
  • Develop state-specific guidelines and recommendations, as indicated.
  • Ensure that TB-related training and education resources are available and disseminated to local health departments, health care professionals and others.
  • Provide telephone consultation regarding a variety of TB-related issues to health care providers, local public health agencies, long term care facilities, correctional facilities, workplaces, the general public, and others.
  • Plan to convene a tuberculosis advisory committee.

4. Screening and Follow-up of Immigrants and Refugees at Risk for TB

  • Receive paperwork from the CDC Division of Quarantine and Global Migration regarding all primary refugees and immigrants identified overseas with TB-related medical findings; review records for TB follow-up needs and assist in referring individuals to local public health agencies for follow-up medical evaluation after arriving in Minnesota.
  • Track TB screening results and outcome of treatment of TB disease or latent TB infection among newly arrived refugees and immigrants with TB class conditions.
  • Report programmatic outcomes to CDC.

5. TB Medications Service

  • Provide medications for TB patients statewide who are receiving treatment for TB disease or latent TB infection.

Tuberculosis Prevention and Control Program Objectives for Minnesota, 2019

Treatment and Case Management of People with Active TB
Program Performance Objectives for 2019
Indicator 2019
1 Completion of treatment within 12 months for eligible cases 95%
2 Drug-susceptibility results reported for culture-positive cases 100%
3 Treatment initiation within 7 days of sputum collection (for cases with positive sputum acid-fast bacilli (AFB) smear results) 98%
4 Sputum culture conversion documented within 60 days of treatment initiation 72%
5 Recommended initial (4-drug) therapy 94%
6 Universal genotyping of culture-positive cases 100%
7 Known HIV status for all TB cases 94%
8 Sputum culture reported for pleural or respiratory TB cases age >=12 years 96%


TB Contact Investigations
Program Performance Objectives for 2019
Indicator 2019
1 Sputum smear-positive cases with contacts elicited 100%
2 Evaluation of contacts of sputum smear-positive cases 90%
3 Contacts with newly-diagnosed latent TB infection (LTBI) who initiate treatment for LTBI (for sputum smear-positive cases) 91%
4 Contacts with newly-diagnosed LTBI who start and complete treatment (for sputum smear-positive cases) 79%
5 Completeness of Reporting core Aggregate Reports for Tuberculosis Program Evaluation (ARPE) Variables 100%

Evaluation of Immigrants and Refugees, and Non-U.S.-born TB and LTBI Cases
Program Performance Objectives for 2019
Indicator 2019
1 Evaluation initiated within 30 days of arrival for refugees and immigrants with chest x-rays (CXR) read overseas as consistent with active TB 64.8%
2 Evaluation completion within 90 days of arrival for refugees and immigrants with CXRs read overseas as consistent with active TB 62.0%
3 Latent TB infection (LTBI) treatment initiated for refugees and immigrants with CXRs read overseas as consistent with active TB and are diagnosed with LTBI in the U.S. 87.3%
4 LTBI treatment completed for refugees and immigrants with CXRs read overseas as consistent with active TB and are diagnosed with LTBI in the U.S. and started on LTBI treatment 75.7%

Contact Information

Phone: 651-201-5414 or 1-877-676-5414

Fax: 1-800-296-0993

TB Prevention and Control Program
Minnesota Department of Health
P.O. Box 64975
St. Paul, MN 55164-0975

Updated Thursday, 24-Jun-2021 09:52:24 CDT